Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361881 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
A Phase 3 study of Herpes Labialis, sponsored by Medivir.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,443
- Enrollment target
- 1
- Study location
NCT00361881: Completed Phase 3 study of Herpes Labialis, sponsored by Medivir.
NCT00361881 is a Phase 3 study of Herpes Labialis that has completed, run by Medivir. The registered enrollment target is 1,443 participants, above the 822-participant average among 6 other Herpes Labialis trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00361881, a Phase 3 study of Herpes Labialis, has completed, sponsored by Medivir.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,443 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether ME-609 is more efficient than acyclovir and placebo for the treatment of recurrent herpes labialis.
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG ME-609
- DRUG acyclovir in ME-609 vehicle
Study Locations (1)
South Carolina
- Coastal Caroline Research Center - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,443 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
What the finished NCT00361881 record still lists
NCT00361881 is an interventional study that assigns participants to a tested intervention. Its 1,443 participants enrollment target places it among the larger protocols in the corpus, above the 822-participant average among 6 other Herpes Labialis trials with a reported enrollment target (76% higher).
The record links to 1 condition, with Herpes Labialis appearing as the primary indexed condition, and to 3 interventions - of which Vehicle is the first listed.
NCT00361881 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00361881 about?
NCT00361881 is a clinical study titled "Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis". The purpose of this study is to determine whether ME-609 is more efficient than acyclovir and placebo for the treatment of recurrent herpes labialis.
What is the current status of trial NCT00361881?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,443 participants. The study started on 2006-07. Estimated completion is 2007-12.
What conditions does trial NCT00361881 study?
This clinical trial studies the following conditions: Herpes Labialis.
What interventions are being tested in trial NCT00361881?
The interventions under investigation include: Vehicle (DRUG), ME-609 (DRUG), acyclovir in ME-609 vehicle (DRUG).
Who is sponsoring clinical trial NCT00361881?
This trial is sponsored by Medivir, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00361881 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Herpes Labialis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 3 Clinical Study for the Treatment of Cold Sore
COMPLETED · Phase 3
-
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
COMPLETED · Phase 3
-
Viral Infections in Healthy and Immunocompromised Hosts
RECRUITING
-
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
COMPLETED · Phase 2
-
Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
COMPLETED · Phase 2
-
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia